MD - Tufts University School of Medicine, Boston, MA
Pediatrics - Children's Hospital at Montefiore, Bronx, NY
Gastroenterology, Hepatology and Nutrition - Children's Hospital of Philadelphia, Philadelphia, PA
Fusillo S, Rudolph B: Nonalcoholic fatty liver disease. Pediatr Rev 36(5): 198-205, May 2015.
Fusillo SJ, Chang V, Stein RE, Maxwell EC, Conrad MA, Albenberg LG, Grossman AB, Mamula P, Piccoli DA, Baldassano RN, Kelsen JR. Ustekinumab Responders Versus Non-responders in Refractory Pediatric Inflammatory Bowel Disease. Oral Presentation, Digestive Disease Week, Washington, DC. June 2018
Fusillo SJ, Olson T, Conrad M, Baldassano R, Grossman A, Kelsen J: Infliximab Dose De-escalation in Pediatric Inflammatory Bowel Disease: A Single-Center Experience, Poster Presentation. North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition Annual Meeting, Las Vegas, NV Nov 2017.
Fusillo SJ, Chang V, Albenberg L, Baldassano R, Conrad MA, Grossman A, Mamula P, Maxwell E, Piccoli D, Stein R, Kelsen J: Ustekinumab Therapy in Severe Pediatric Inflammatory Bowel Disease, Poster Presentation. North American Society of Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, Las Vegas, NV Nov 2017.
Fusillo S, Kelsen J, Ruchelli E: Infantile Hyaline Fibromatosis: A Rare Cause of Neonatal Diarrhea, Poster Presentation. The World Congress of Pediatric Gastroenterology, Hepatology and Nutrition, Montreal QB Oct 2016.
2018, Komarov Research Symposium, 2nd Prize, "Ustekinumab Therapy in Refractory Pediatric Inflammatory Bowel Disease"
2015, Inductee, Leo M. Davidoff Society of the Albert Einstein College of Medicine
2013-present, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
2017-present, American Gastroenterological Association
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.